Bickling Financial Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$823K Buy
8,836
+49
+0.6% +$4.73K 0.51% 42
2022
Q3
$839K Buy
8,787
+46
+0.5% +$4.55K 0.57% 40
2022
Q2
$810K Buy
8,741
+51
+0.6% +$4.98K 0.51% 43
2022
Q1
$880K Sell
8,690
-10
-0.1% -$1.05K 0.45% 46
2021
Q4
$898K Buy
8,700
+45
+0.5% +$4.16K 0.44% 42
2021
Q3
$734K Buy
8,655
+49
+0.6% +$4.1K 0.37% 49
2021
Q2
$718K Buy
+8,606
New +$705K 0.32% 51

Other funds holding CVS

Bickling Financial Services's CVS Position: Q4 2022 in Review

Bickling Financial Services increased its CVS Health (CVS) stake by 0.56% in Q4 2022, buying an estimated $4.73K and bringing the position to 8,836 shares worth $823K. The position accounts for 0.51% of the portfolio, ranked #42.

Bickling Financial Services first reported a position in CVS in Q2 2021 and has held it in 7 quarters since. The position peaked at $898K in Q4 2021. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Bickling Financial Services held 8,836 shares of CVS Health worth $823K as of Q4 2022.
  • Bickling Financial Services bought 49 CVS Health shares in Q4 2022, an estimated $4.73K.
  • CVS Health made up 0.51% of Bickling Financial Services's portfolio in Q4 2022, its #42 holding.
  • Bickling Financial Services first reported a position in CVS Health in Q2 2021 and has held it in 7 quarters since.
  • Bickling Financial Services's CVS Health position peaked at $898K in Q4 2021.
  • 2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Bickling Financial Services's 13F filing for Q4 2022, filed 31 Jan 2023.